TScan Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| LYNX1 CAPITAL MANAGEMENT LP | 02/14/2025 | 5.36 M | $16.29 M | 2.54% | 4.51% |
| ECOR1 CAPITAL, LLC | 02/14/2025 | 5.00 M | $15.20 M | 0.00% | 4.21% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 4.96 M | $15.08 M | 7.10% | 4.18% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 3.50 M | $10.64 M | -20.45% | 2.95% |
| BVF INC/IL | 02/14/2025 | 2.99 M | $9.09 M | 0.00% | 2.52% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 2.78 M | $8.47 M | 0.00% | 2.35% |
| VANGUARD GROUP INC | 02/11/2025 | 2.38 M | $7.24 M | 1.52% | 2.01% |
| PROPEL BIO MANAGEMENT, LLC | 02/14/2025 | 2.09 M | $6.34 M | 0.00% | 1.76% |
| CHECKPOINT CAPITAL L.P. | 02/14/2025 | 1.76 M | $5.34 M | 112.76% | 1.48% |
| DEER MANAGEMENT CO. LLC | 02/14/2025 | 1.25 M | $3.79 M | 0.00% | 1.05% |
| ALPHABET INC. | 02/07/2025 | 1.08 M | $3.27 M | 0.00% | 0.91% |
| SIMPLIFY ASSET MANAGEMENT INC. | 02/11/2025 | 1.05 M | $3.18 M | 0.00% | 0.88% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 963,257 | $2.93 M | -1.05% | 0.81% |
| ABRDN PLC | 01/24/2025 | 883,704 | $2.69 M | 137.78% | 0.74% |
| DC FUNDS, LP | 02/14/2025 | 630,000 | $1.92 M | 0.00% | 0.53% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 280,028 | $851,187 | 108.51% | 0.24% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 02/10/2025 | 260,870 | $793,045 | 26.80% | 0.22% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 160,673 | $488,446 | 1.29% | 0.14% |
| BROWN BROTHERS HARRIMAN & CO | 02/12/2025 | 143,051 | $434,875 | 0.00% | 0.12% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 132,895 | $404,000 | 5.18% | 0.11% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 117,847 | $358,255 | 100.00% | 0.10% |
| WOODLINE PARTNERS LP | 02/14/2025 | 115,866 | $352,233 | 6.71% | 0.10% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 112,941 | $343,341 | 0.00% | 0.10% |
| 02/14/2025 | 110,345 | $335,449 | 100.00% | 0.09% | |
| STIFEL FINANCIAL CORP | 02/13/2025 | 109,700 | $333,488 | 10.66% | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 105,900 | $321,936 | 176.50% | 0.09% |
| UBS GROUP AG | 02/14/2025 | 91,860 | $279,254 | 374.88% | 0.08% |
| NEWEDGE WEALTH, LLC | 02/05/2025 | 91,463 | $278,048 | 0.00% | 0.08% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 88,314 | $268,475 | 0.00% | 0.07% |
| LMR PARTNERS LLP | 02/14/2025 | 71,800 | $218,272 | 0.00% | 0.06% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 69,962 | $212,684 | 0.00% | 0.06% |
| BARCLAYS PLC | 02/13/2025 | 67,508 | $206,000 | 16.26% | 0.06% |
| JPMORGAN CHASE & CO | 02/12/2025 | 66,756 | $202,938 | 109.89% | 0.06% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 65,139 | $198,023 | 100.00% | 0.05% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 63,095 | $191,809 | 96.33% | 0.05% |
| TROLUCE CAPITAL ADVISORS LLC | 02/14/2025 | 52,914 | $160,859 | 0.00% | 0.04% |
| RHUMBLINE ADVISERS | 01/30/2025 | 46,807 | $142,287 | -0.84% | 0.04% |
| MARSHALL WACE, LLP | 02/13/2025 | 43,969 | $133,666 | -73.38% | 0.04% |
| PALE FIRE CAPITAL SE | 02/13/2025 | 43,723 | $132,918 | 0.00% | 0.04% |
| CITIGROUP INC | 02/12/2025 | 40,243 | $122,339 | 44.80% | 0.03% |
| LETKO, BROSSEAU & ASSOCIATES INC | 02/14/2025 | 36,200 | $110,048 | 74.88% | 0.03% |
| DC INVESTMENTS MANAGEMENT, LLC | 02/14/2025 | 35,563 | $108,112 | 0.00% | 0.03% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 25,835 | $78,538 | 153.88% | 0.02% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 22,214 | $67,531 | 4.45% | 0.02% |
| SHAY CAPITAL LLC | 02/14/2025 | 21,363 | $64,944 | 100.00% | 0.02% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 21,078 | $64,077 | 2.13% | 0.02% |
| INVESCO LTD. | 02/13/2025 | 20,628 | $62,709 | 14.50% | 0.02% |
| 01/23/2025 | 20,120 | $61,165 | 100.00% | 0.02% | |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 19,540 | $59,402 | 41.12% | 0.02% |
| SQUAREPOINT OPS LLC | 02/14/2025 | 19,461 | $59,161 | 100.00% | 0.02% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
TScan Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 98 institutional investors and hedge funds held shares of TScan Therapeutics, Inc.. The most heavily invested institutionals were:
Lynx1 Capital Management LP: 5.36 M
EcoR1 Capital, LLC: 5 M
BlackRock Funding, Inc. /DE: 4.96 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 3.5 M
BVF INC/IL: 2.99 M
BAKER BROS. ADVISORS LP: 2.78 M
34.99% of TScan Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 46.28 M shares in the last 24 months. This purchase volume represents approximately $137.90 M in transactions.